Mission Bay Capital backs Circle Pharma
San Francisco-based early-stage biotech firm Circle Pharma said Monday that it has secured an undisclosed amount of seed funding. The investors were Pfizer and QB3’s seed-stage venture fund Mission Bay Capital.
22 September 2014•2 mins read
